Abstract:
A novel therapeutic composition comprises three novel herbal extracts: Herba epimedium Extract, Rhizoma Drynaria fortunei (kze.) J. Sm Extract and Radix Tripterygium hypoglaucum (L'evl.) Hutch Extract, which are prepared through standardized manufacturing processes, respectively. A new formulation AHT-323 contains these three herbal extracts. The novel therapeutic composition described in the present application can be used for treating autoimmune diseases such as rheumatoid arthritis, inflammatory disorders and pain.